Using light to activate cancer treatment

Season 07 of Startup Passport by Frontwalker continues with Episode 10 – Sebas Pronk, CEO and Co-founder of Lumox. A biomedical scientist turned entrepreneur, Sebas is on a mission to transform cancer treatment through precision medicine. In this episode, he shares how Lumox is developing a light-activated therapy designed to target tumors more precisely, reducing damage to healthy cells while improving treatment effectiveness. He explains how a breakthrough in academic research evolved into a startup with the potential to change the future of cancer care. Sebas also shares the journey of transforming breakthrough scientific research into a healthcare startup, from laboratory discovery and pre-clinical studies to preparing for human clinical trials. He discusses the realities of developing medical innovation, the importance of securing investment, and why bringing a new therapy to patients requires patience, collaboration, and long-term vision. Reflecting on his entrepreneurial journey, Sebas explains why great science alone isn't enough, how storytelling became just as important as research, and why the support of the startup ecosystem has been one of his biggest lessons as a founder. This new season brings conversations with founders, innovators, investors, and ecosystem leaders shaping the future of entrepreneurship, recorded in partnership with Erasmus Enterprise and the NL Startup Competition. These conversations are powerful, inspiring, and game-changing, and we can't wait for you to hear them. Stay tuned! New episodes dropping soon!